RBC Capital Reiterates Outperform Rating on Xylem (XYL)
Tweet Send to a Friend
RBC Capital analyst Deane Dray reiterated an Outperform rating and $162.00 price target on Xylem (NYSE: XYL).The analyst comments "Outperform-rated ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


